180 related articles for article (PubMed ID: 37445934)
1. Brk/PTK6 and Involucrin Expression May Predict Breast Cancer Cell Responses to Vitamin D3.
Box C; Pennington C; Hare S; Porter S; Edwards D; Eccles S; Crompton M; Harvey A
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445934
[TBL] [Abstract][Full Text] [Related]
2. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
[TBL] [Abstract][Full Text] [Related]
3. Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes.
Tupper J; Crompton MR; Harvey AJ
Arch Dermatol Res; 2011 May; 303(4):293-7. PubMed ID: 21240512
[TBL] [Abstract][Full Text] [Related]
4. BRK tyrosine kinase expression in a high proportion of human breast carcinomas.
Barker KT; Jackson LE; Crompton MR
Oncogene; 1997 Aug; 15(7):799-805. PubMed ID: 9266966
[TBL] [Abstract][Full Text] [Related]
5. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
Castro NE; Lange CA
Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
[TBL] [Abstract][Full Text] [Related]
6. Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation.
Harvey AJ; Crompton MR
Oncogene; 2003 Aug; 22(32):5006-10. PubMed ID: 12902983
[TBL] [Abstract][Full Text] [Related]
7. The vitamin D response element of the involucrin gene mediates its regulation by 1,25-dihydroxyvitamin D3.
Bikle DD; Ng D; Oda Y; Hanley K; Feingold K; Xie Z
J Invest Dermatol; 2002 Nov; 119(5):1109-13. PubMed ID: 12445200
[TBL] [Abstract][Full Text] [Related]
8. Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro.
Burmi RS; Box GM; Wazir U; Hussain HA; Davies JA; Court WJ; Eccles SA; Jiang WG; Mokbel K; Harvey AJ
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327957
[TBL] [Abstract][Full Text] [Related]
9. Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.
Regan Anderson TM; Peacock DL; Daniel AR; Hubbard GK; Lofgren KA; Girard BJ; Schörg A; Hoogewijs D; Wenger RH; Seagroves TN; Lange CA
Cancer Res; 2013 Sep; 73(18):5810-20. PubMed ID: 23928995
[TBL] [Abstract][Full Text] [Related]
10. PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors.
Peng M; Emmadi R; Wang Z; Wiley EL; Gann PH; Khan SA; Banerji N; McDonald W; Asztalos S; Pham TN; Tonetti DA; Tyner AL
Oncotarget; 2014 Aug; 5(15):6038-48. PubMed ID: 25153721
[TBL] [Abstract][Full Text] [Related]
11. Role of breast tumour kinase in the in vitro differentiation of HaCaT cells.
Wang TC; Jee SH; Tsai TF; Huang YL; Tsai WL; Chen RH
Br J Dermatol; 2005 Aug; 153(2):282-9. PubMed ID: 16086737
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 1,25-dihydroxyvitamin-D-induced keratinocyte differentiation by blocking the expression of phospholipase C-gamma1.
Xie Z; Bikle DD
J Invest Dermatol; 2001 Nov; 117(5):1250-4. PubMed ID: 11710940
[TBL] [Abstract][Full Text] [Related]
13. Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.
Ai M; Liang K; Lu Y; Qiu S; Fan Z
Cancer Biol Ther; 2013 Mar; 14(3):237-45. PubMed ID: 23291984
[TBL] [Abstract][Full Text] [Related]
14. Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR.
Li X; Lu Y; Liang K; Hsu JM; Albarracin C; Mills GB; Hung MC; Fan Z
Oncogene; 2012 Oct; 31(40):4372-83. PubMed ID: 22231447
[TBL] [Abstract][Full Text] [Related]
15. PPAR gamma is an important transcription factor in 1 alpha,25-dihydroxyvitamin D3-induced involucrin expression.
Dai X; Sayama K; Shirakata Y; Tokumaru S; Yang L; Tohyama M; Hirakawa S; Hanakawa Y; Hashimoto K
J Dermatol Sci; 2008 Apr; 50(1):53-60. PubMed ID: 18077140
[TBL] [Abstract][Full Text] [Related]
16. Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK.
Brauer PM; Tyner AL
Biochim Biophys Acta; 2010 Aug; 1806(1):66-73. PubMed ID: 20193745
[TBL] [Abstract][Full Text] [Related]
17. Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia.
Mizuguchi Y; Specht S; Isse K; Sasatomi E; Lunz JG; Takizawa T; Demetris AJ
J Hepatol; 2015 Aug; 63(2):399-407. PubMed ID: 25770659
[TBL] [Abstract][Full Text] [Related]
18. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.
Weaver AM; Silva CM
Breast Cancer Res; 2007; 9(6):R79. PubMed ID: 17997837
[TBL] [Abstract][Full Text] [Related]
19. The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary.
Schmandt RE; Bennett M; Clifford S; Thornton A; Jiang F; Broaddus RR; Sun CC; Lu KH; Sood AK; Gershenson DM
Cancer Biol Ther; 2006 Sep; 5(9):1136-41. PubMed ID: 16855388
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
